Learn about RECIST 1.1 and how it can be applied to your clinical trial.
RECIST (Response Evaluation Criteria In Solid Tumors) is a set of published rules that define when cancer patients improve ("respond"), stay the same ("stable") or worsen ("progression") during treatments.
This app has been updated by Apple to display the Apple Watch app icon.Improved RECIST calculations which includes percent changes from Nadir.User can enter Baseline and up to 9 follow up time points.Target lesion measurements can be designated as lymph nodes.
~PAREXEL International Corporation
2.0.1 2.0.1
This app has been updated by Apple to display the Apple Watch app icon.Improved RECIST calculations which includes percent changes from Nadir.User can enter Baseline and up to 9 follow up time points.Target lesion measurements can be designated as lymph nodes.